EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $119 | -17.9% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $145 | -99.9% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $201,000 | +3.6% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $194,000 | -37.8% | 16,400 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $312,000 | -28.3% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $435,000 | -35.5% | 16,400 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $674,000 | -27.4% | 16,400 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $929,000 | +108.8% | 16,400 | +54.7% | 0.01% | +66.7% |
| Q1 2021 | $445,000 | -32.5% | 10,600 | +12.8% | 0.00% | -25.0% |
| Q4 2020 | $659,000 | +149.6% | 9,400 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $264,000 | -52.5% | 9,400 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $556,000 | -81.9% | 18,800 | -86.1% | 0.00% | -96.8% |
| Q4 2018 | $3,071,000 | -64.3% | 135,000 | -50.0% | 0.06% | -41.5% |
| Q3 2018 | $8,592,000 | +99.8% | 270,000 | +125.0% | 0.11% | +26.2% |
| Q2 2018 | $4,300,000 | – | 120,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |